Back
Avista Vs. United Therapeutics Industry Stock Comparison
Buy
69
AVA
Avista
Last Price:
$38.33
Seasonality Move:
0.65%
Buy
54
UTHR
United Therapeutics
Last Price:
$294.27
Seasonality Move:
7.07%
Buy
54
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy, Sell or Hold?
-
The current United Therapeutics [UTHR] share price is $295.22. The Score for UTHR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AVA Stock Price Chart
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $295.22The current trend is relatively stagnant and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
AVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 50.3 | Buy |
Chaikin Money Flow: | -275620 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.33 - 38.21) | Buy |
Bollinger Bands (100): | (37.67 - 40.85) | Sell |
UTHR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.56 | Sell |
Relative Strength Index (14 RSI): | 49.75 | Sell |
Chaikin Money Flow: | 298346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (282.05 - 317.29) | Sell |
Bollinger Bands (100): | (286.18 - 334.08) | Sell |
AVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.95 | Buy |
20-day SMA: | 37.63 | Buy |
50-day SMA: | 38.94 | Sell |
200-day SMA: | 38.33 | Sell |
8-day EMA: | 37.93 | Buy |
20-day EMA: | 37.93 | Buy |
50-day EMA: | 38.5 | Sell |
200-day EMA: | 38.32 | Sell |
UTHR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 288.02 | Buy |
20-day SMA: | 294.36 | Buy |
50-day SMA: | 300.98 | Sell |
200-day SMA: | 337.02 | Sell |
8-day EMA: | 289.82 | Buy |
20-day EMA: | 293.53 | Buy |
50-day EMA: | 300.41 | Sell |
200-day EMA: | 316.49 | Sell |
Avista Earnings Growth & AVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.10 per share, an increase this year of $0.23 per share, and an increase next year of $0.19 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.15 per share, an increase this year of $2.52 per share, and an increase next year of $0.95 per share.
Avista Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
United Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |